Cargando…
Near-Infrared Spectroscopy Demonstrates the Benefit of Erythracytapheresis in Sickle Cell Disease Adult Patients with Cerebral Vasculopathy
Background: Cerebral vasculopathy can induce chronic cerebral hypoperfusion leading to stroke in patients with sickle cell disease (SCD) and is treated by blood exchange transfusion (BET). However, no prospective clinical study has demonstrated the benefit of BET in adults with SCD and cerebral vasc...
Autores principales: | Martino, Suella, Turki, Rym Chouk, Zouiti, Fouzia, Fort, Romain, Pakdaman, Sadaf, Forté, Stéphanie, Menouche, Dehbia, Calvet, David, Rupp, Thomas, Pirenne, France, Bartolucci, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966188/ https://www.ncbi.nlm.nih.gov/pubmed/36835792 http://dx.doi.org/10.3390/jcm12041256 |
Ejemplares similares
-
Preclinical evaluation of the preservation of red blood cell concentrates by hypoxic storage technology for transfusion in sickle cell disease
por: Bencheikh, Laura, et al.
Publicado: (2022) -
Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors
por: Leclerc, Mathieu, et al.
Publicado: (2021) -
Drepadom - Establishment of Home Care Services and Hospitalizations for Sickle Cell Disease Patients As Standard Care Since the Covid-19 Pandemic
por: Pelinski, Yanís, et al.
Publicado: (2021) -
Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal
por: Thein, Swee Lay, et al.
Publicado: (2020) -
Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease
por: Floch, Aline, et al.
Publicado: (2020)